| NASDAQ (usa) |
|
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
| DAX (german) |
|
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
MicroPort CardioFlow Medtech Corporation (HK: 2160)
2160 Technical Analysis
5
| As on 31st Mar 2026 2160 STOCK Price closed @ 2.70 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 1.03 & Strong Buy for SHORT-TERM with Stoploss of 0.73 we also expect STOCK to react on Following IMPORTANT LEVELS. |
2160STOCK Price
| Open | 3.02 | Change | Price | % |
| High | 3.06 | 1 Day | -0.36 | -11.76 |
| Low | 2.54 | 1 Week | -0.52 | -16.15 |
| Close | 2.70 | 1 Month | 1.91 | 241.77 |
| Volume | 7005000 | 1 Year | 2.00 | 285.71 |
| 52 Week High 3.72 | 52 Week Low 0.65 | ||||
HK Hong Kong Most Active Stocks
| CSHK100 | 2401.56 | 0.95% |
| 43 | 1.14 | 0.00% |
| 3988 | 4.97 | 1.64% |
| 0939 | 8.39 | 1.82% |
| 1398 | 6.86 | 1.78% |
| 0020 | 1.84 | -1.08% |
| 0020-OL | 1.84 | -1.08% |
| 2007 | 0.32 | 0.00% |
| 0857 | 10.75 | -3.50% |
| 0883 | 28.00 | -3.11% |
HK Hong Kong Top Gainers Stocks
HK Hong Kong Top Losers Stocks
| 2160 Daily Charts |
2160 Intraday Charts |
Whats New @ Bazaartrend |
2160 Free Analysis |
|
|
2160 Important Levels Intraday
| RESISTANCE | 3.70 |
| RESISTANCE | 3.38 |
| RESISTANCE | 3.18 |
| RESISTANCE | 2.98 |
| SUPPORT | 2.42 |
| SUPPORT | 2.22 |
| SUPPORT | 2.02 |
| SUPPORT | 1.70 |
2160 Forecast April 2026
| 4th UP Forecast | 2.95 |
| 3rd UP Forecast | 2.87 |
| 2nd UP Forecast | 2.82 |
| 1st UP Forecast | 2.77 |
| 1st DOWN Forecast | 2.63 |
| 2nd DOWN Forecast | 2.58 |
| 3rd DOWN Forecast | 2.53 |
| 4th DOWN Forecast | 2.45 |
2160 Weekly Forecast
| 4th UP Forecast | 2.85 |
| 3rd UP Forecast | 2.80 |
| 2nd UP Forecast | 2.77 |
| 1st UP Forecast | 2.74 |
| 1st DOWN Forecast | 2.66 |
| 2nd DOWN Forecast | 2.63 |
| 3rd DOWN Forecast | 2.60 |
| 4th DOWN Forecast | 2.55 |
2160 Forecast2026
| 4th UP Forecast | 8.98 |
| 3rd UP Forecast | 6.97 |
| 2nd UP Forecast | 5.72 |
| 1st UP Forecast | 4.48 |
| 1st DOWN Forecast | 0.92 |
| 2nd DOWN Forecast | -0.32 |
| 3rd DOWN Forecast | -1.57 |
| 4th DOWN Forecast | -3.58 |
MicroPort CardioFlow Medtech Corporation ( HK Hong Kong Symbol : 2160 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
2160 Other Details
| Segment | EQ | |
| Market Capital | 12438474752.00 | |
| Sector | Healthcare | |
| Industry | Medical Devices | |
| Offical website | > echo $website ; ?> | |
2160 Address
![]() |
||
2160 Latest News
2160 Business Profile
MicroPort CardioFlow Medtech Corporation, a medical device company, focuses on the research, development, and commercialization of transcatheter and surgical solutions for valvular heart diseases in the People's Republic of China. Its products include Vitaflow Aortic Valve System, Alwide Balloon Catheter, and Alpass Introducer Set, which targets aortic, mitral, tricuspid, and surgical valves, as well as procedural accessories. The company was founded in 2010 and is headquartered in Shanghai, China. MicroPort CardioFlow Medtech Corporation is a subsidiary of Shanghai MicroPort Limited. Address: No. 1601 Zhangdong Road, Shanghai, China, 201203
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service

